Clinics · 2012 · 34 citations · 28 references
Veterinary MedicineImmunologyPhysiologyInflammationMucosal ImmunologySepsisGastrointestinal InflammationOxidative Stress In InflammationOxidative Stress PhysiologySepsis ManagementSepsis PathophysiologySeptic ShockAcute Inflammatory ResponseHemodynamic Stability ManagementLipid Peroxidation MarkersOxidative Stress InjurySepsis Fluid ManagementSeptic Shock ManagementThiobarbituric Acid Reactive SubstancesVolume Replacement During Autologous Donation
OBJECTIVE: Volume replacement in septic patients improves hemodynamic stability. This effect can reduce the inflammatory response. The objective of this study was to evaluate the effect of 7.5% hypertonic saline solution versus 0.9% normal saline solution for volume replacement during an inflammatory response in endotoxemic rats. METHODS: We measured cytokines (serum and gut), nitrite, and lipid peroxidation (TBARS) as indicators of oxidative stress in the gut. Rats were divided into four groups: control group (C) that did not receive lipopolysaccharide; lipopolysaccharide injection without treatment (LPS); lipopolysaccharide injection with saline treatment (LPS +S); and lipopolysaccharide injection with hypertonic saline treatment (LPS +H). Serum and intestine were collected. Measurements were taken at 1.5, 8, and 24 h after lipopolysaccharide administration. RESULTS: Of the four groups, the LPS +H group had the highest survival rate. Hypertonic saline solution treatment led to lower levels of IL-6, IL-10, nitric oxide, and thiobarbituric acid reactive substances compared to 0.9% normal saline. In addition, hypertonic saline treatment resulted in a lower mortality compared to 0.9% normal saline treatment in endotoxemic rats. Volume replacement reduced levels of inflammatory mediators in the plasma and gut. CONCLUSION: Hypertonic saline treatment reduced mortality and lowered levels of inflammatory mediators in endotoxemic rats. Hypertonic saline also has the advantage of requiring less volume replacement.
28
IL-10 inhibits cytokine production by activated macrophages
David Fiorentino, Albert Zlotnik, Tim R. Mosmann et al. · The Journal of Immunology · 1991 · 2.9K citations · Full text
Daniel Berg, Ralf Kühn, Klaus Rajewsky et al. · Journal of Clinical Investigation · 1995 · 539 citations · Full text
Life Sciences, Immunology, Pathology +16
Francisco García Soriano, Antônio Carlos Nogueira, Élia Garcia Caldini et al. · Critical Care Medicine · 2006 · 174 citations